drugset / Trial / NCT03514810

Combined Sertraline and Ketoprofen Administration in Major Depressive Disorder

NCT03514810

Phase 1 Completed 28 enrolled Kufa University
RandomizedCrossoverQuadruple-blindTreatment

Summary

Among the major depressive disorder (MDD) patients in the follow-up group, 16 were administered with 50 mg of oral sertralin once daily with placebo, whereas 28 were treated with 100 mg of ketoprofen once daily as adjuvant treatment for MDD. Controls do not take any medicine.

Timeline

Start
2017-01-10
Primary completion
2017-09-10
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule 100 mg
Background Sertraline Small molecule 50 mg Oral